FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4378347650> ?p ?o ?g. }

• W4378347650 endingPage "1074" @default.
• W4378347650 startingPage "1066" @default.
• W4378347650 abstract "We hypothesized that total body weight (TBW) gain after switching antiretroviral therapy (ART) regimen to tenofovir disoproxil fumarate/lamivudine/dolutegravir (TLD) may negatively impact ART adherence and viral load (VL) and therefore sought to examine these associations.The ongoing African Cohort Study (AFRICOS) enrols people with HIV at 12 facilities in Kenya, Nigeria, Tanzania and Uganda supported by The US President's Emergency Plan for AIDS Relief. Among ART-experienced participants who switched to TLD, we used multivariable multinomial logistic regression to examine associations between pre-/post-TLD changes in percentage TBW (≥5% gain, <5% change, ≥5% loss) and changes in self-reported ART adherence (0, 1-2, ≥3 days missed doses in past 30 days) and VL [(<50 copies/mL (undetectable), 50-999 copies/mL (detectable, but suppressed), ≥1000 copies/mL (unsuppressed)].Among 1508 participants, median time from starting TLD to follow-up was 9 months (interquartile range: 7-11). Overall, 438 (29.1%) participants experienced a TBW gain ≥5%, which was more common among females than among males (32.2% vs 25.2%, p = 0.005) and participants switching from efavirenz [32.0% vs nevirapine (19.9%) and boosted protease inhibitor (20.0%); p < 0.001]. Compared with a TBW change <5% [950 (63.0%) participants], TBW gain ≥5% was not significantly associated with more days with missed ART doses [adjusted odds ratio (aOR) = 0.77, 95% confidence interval (CI): 0.48-1.23] or VL becoming detectable and/or unsuppressed (aOR = 0.69, 95% CI: 0.41-1.16).Although a substantial proportion of participants experienced weight gain after switching to TLD, we did not identify a significant impact on adherence or virological outcomes." @default.
• W4378347650 created "2023-05-27" @default.
• W4378347650 creator A5000644503 @default.
• W4378347650 creator A5002708685 @default.
• W4378347650 creator A5008887687 @default.
• W4378347650 creator A5030331591 @default.
• W4378347650 creator A5036713456 @default.
• W4378347650 creator A5037033610 @default.
• W4378347650 creator A5052150473 @default.
• W4378347650 creator A5059685154 @default.
• W4378347650 creator A5062901582 @default.
• W4378347650 creator A5064959555 @default.
• W4378347650 creator A5069193306 @default.
• W4378347650 creator A5070877757 @default.
• W4378347650 date "2023-05-25" @default.
• W4378347650 modified "2023-10-17" @default.
• W4378347650 title "Impact of weight gain with dolutegravir on antiretroviral adherence and viral suppression in four African countries" @default.
• W4378347650 cites W2006307611 @default.
• W4378347650 cites W2085667522 @default.
• W4378347650 cites W2146830005 @default.
• W4378347650 cites W2903089706 @default.
• W4378347650 cites W3025713364 @default.
• W4378347650 cites W3087059482 @default.
• W4378347650 cites W3089405003 @default.
• W4378347650 cites W3090200844 @default.
• W4378347650 cites W3093018885 @default.
• W4378347650 cites W3096797127 @default.
• W4378347650 cites W4205402487 @default.
• W4378347650 cites W4220686559 @default.
• W4378347650 cites W4223917991 @default.
• W4378347650 cites W4283212854 @default.
• W4378347650 cites W4283214101 @default.
• W4378347650 cites W4296425952 @default.
• W4378347650 cites W4320475007 @default.
• W4378347650 cites W4320716652 @default.
• W4378347650 doi "https://doi.org/10.1111/hiv.13501" @default.
• W4378347650 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37232057" @default.
• W4378347650 hasPublicationYear "2023" @default.
• W4378347650 type Work @default.
• W4378347650 citedByCount "0" @default.
• W4378347650 crossrefType "journal-article" @default.
• W4378347650 hasAuthorship W4378347650A5000644503 @default.
• W4378347650 hasAuthorship W4378347650A5002708685 @default.
• W4378347650 hasAuthorship W4378347650A5008887687 @default.
• W4378347650 hasAuthorship W4378347650A5030331591 @default.
• W4378347650 hasAuthorship W4378347650A5036713456 @default.
• W4378347650 hasAuthorship W4378347650A5037033610 @default.
• W4378347650 hasAuthorship W4378347650A5052150473 @default.
• W4378347650 hasAuthorship W4378347650A5059685154 @default.
• W4378347650 hasAuthorship W4378347650A5062901582 @default.
• W4378347650 hasAuthorship W4378347650A5064959555 @default.
• W4378347650 hasAuthorship W4378347650A5069193306 @default.
• W4378347650 hasAuthorship W4378347650A5070877757 @default.
• W4378347650 hasBestOaLocation W43783476501 @default.
• W4378347650 hasConcept C119060515 @default.
• W4378347650 hasConcept C126322002 @default.
• W4378347650 hasConcept C142462285 @default.
• W4378347650 hasConcept C147583825 @default.
• W4378347650 hasConcept C156957248 @default.
• W4378347650 hasConcept C203014093 @default.
• W4378347650 hasConcept C2522874641 @default.
• W4378347650 hasConcept C2777182164 @default.
• W4378347650 hasConcept C2777869810 @default.
• W4378347650 hasConcept C2779130552 @default.
• W4378347650 hasConcept C2779502633 @default.
• W4378347650 hasConcept C2780320433 @default.
• W4378347650 hasConcept C2780593183 @default.
• W4378347650 hasConcept C2781413609 @default.
• W4378347650 hasConcept C2781432083 @default.
• W4378347650 hasConcept C2993143319 @default.
• W4378347650 hasConcept C3013748606 @default.
• W4378347650 hasConcept C44249647 @default.
• W4378347650 hasConcept C71924100 @default.
• W4378347650 hasConcept C72563966 @default.
• W4378347650 hasConceptScore W4378347650C119060515 @default.
• W4378347650 hasConceptScore W4378347650C126322002 @default.
• W4378347650 hasConceptScore W4378347650C142462285 @default.
• W4378347650 hasConceptScore W4378347650C147583825 @default.
• W4378347650 hasConceptScore W4378347650C156957248 @default.
• W4378347650 hasConceptScore W4378347650C203014093 @default.
• W4378347650 hasConceptScore W4378347650C2522874641 @default.
• W4378347650 hasConceptScore W4378347650C2777182164 @default.
• W4378347650 hasConceptScore W4378347650C2777869810 @default.
• W4378347650 hasConceptScore W4378347650C2779130552 @default.
• W4378347650 hasConceptScore W4378347650C2779502633 @default.
• W4378347650 hasConceptScore W4378347650C2780320433 @default.
• W4378347650 hasConceptScore W4378347650C2780593183 @default.
• W4378347650 hasConceptScore W4378347650C2781413609 @default.
• W4378347650 hasConceptScore W4378347650C2781432083 @default.
• W4378347650 hasConceptScore W4378347650C2993143319 @default.
• W4378347650 hasConceptScore W4378347650C3013748606 @default.
• W4378347650 hasConceptScore W4378347650C44249647 @default.
• W4378347650 hasConceptScore W4378347650C71924100 @default.
• W4378347650 hasConceptScore W4378347650C72563966 @default.
• W4378347650 hasFunder F4320307611 @default.
• W4378347650 hasIssue "10" @default.
• W4378347650 hasLocation W43783476501 @default.
• W4378347650 hasLocation W43783476502 @default.

• next